4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane

C55H69N15O4 — CID 158189049

IUPAC4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane
SMILESC.C=CC(=C)Nc1ccc(C(=O)Nc2cccc(Nc3nc(N4CCCCC4CCO)nc4c(CC)cnn34)c2)cc1.C=CC(=O)Nc1cccc(Nc2nc(N3CCCCC3CCO)nc3c(CC)cnn23)c1
InChIInChI=1S/C31H36N8O2.C23H29N7O2.CH4/c1-4-21(3)33-24-14-12-23(13-15-24)29(41)34-25-9-8-10-26(19-25)35-31-37-30(36-28-22(5-2)20-32-39(28)31)38-17-7-6-11-27(38)16-18-40;1-3-16-15-24-30-21(16)27-22(29-12-6-5-10-19(29)11-13-31)28-23(30)26-18-9-7-8-17(14-18)25-20(32)4-2;/h4,8-10,12-15,19-20,27,33,40H,1,3,5-7,11,16-18H2,2H3,(H,34,41)(H,35,36,37);4,7-9,14-15,19,31H,2-3,5-6,10-13H2,1H3,(H,25,32)(H,26,27,28);1H4
InChIKeyFZMZDTQZRLYNAN-UHFFFAOYSA-N
MW1004.26 g/mol
LogP9.47
Rot. Bonds19

About 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane

4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane (PubChem CID 158189049) has the molecular formula C55H69N15O4 and a molecular weight of 1004.26 g/mol. Its IUPAC name is 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane.

Molecular Properties

Compound Name4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane
PubChem CID158189049
Molecular FormulaC55H69N15O4
Molecular Weight1004.26 g/mol
Exact Mass1003.57
IUPAC Name4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane
SMILESC.C=CC(=C)Nc1ccc(C(=O)Nc2cccc(Nc3nc(N4CCCCC4CCO)nc4c(CC)cnn34)c2)cc1.C=CC(=O)Nc1cccc(Nc2nc(N3CCCCC3CCO)nc3c(CC)cnn23)c1
InChIInChI=1S/C31H36N8O2.C23H29N7O2.CH4/c1-4-21(3)33-24-14-12-23(13-15-24)29(41)34-25-9-8-10-26(19-25)35-31-37-30(36-28-22(5-2)20-32-39(28)31)38-17-7-6-11-27(38)16-18-40;1-3-16-15-24-30-21(16)27-22(29-12-6-5-10-19(29)11-13-31)28-23(30)26-18-9-7-8-17(14-18)25-20(32)4-2;/h4,8-10,12-15,19-20,27,33,40H,1,3,5-7,11,16-18H2,2H3,(H,34,41)(H,35,36,37);4,7-9,14-15,19,31H,2-3,5-6,10-13H2,1H3,(H,25,32)(H,26,27,28);1H4
InChIKeyFZMZDTQZRLYNAN-UHFFFAOYSA-N
XLogP9.47
TPSA227.39 Ų
H-Bond Donors7
H-Bond Acceptors17
Rotatable Bonds19
Heavy Atoms74
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001004.26
LogP ≤ 59.47
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane?
The IUPAC name of 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane (CID 158189049) is 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane.
What is the SMILES notation for 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane?
The canonical SMILES for 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane is C.C=CC(=C)Nc1ccc(C(=O)Nc2cccc(Nc3nc(N4CCCCC4CCO)nc4c(CC)cnn34)c2)cc1.C=CC(=O)Nc1cccc(Nc2nc(N3CCCCC3CCO)nc3c(CC)cnn23)c1.
What is the InChIKey of 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane?
The InChIKey is FZMZDTQZRLYNAN-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H36N8O2.C23H29N7O2.CH4/c1-4-21(3)33-24-14-12-23(13-15-24)29(41)34-25-9-8-10-26(19-25)35-31-37-30(36-28-22(5-2)20-32-39(28)31)38-17-7-6-11-27(38)16-18-40;1-3-16-15-24-30-21(16)27-22(29-12-6-5-10-19(29)11-13-31)28-23(30)26-18-9-7-8-17(14-18)25-20(32)4-2;/h4,8-10,12-15,19-20,27,33,40H,1,3,5-7,11,16-18H2,2H3,(H,34,41)(H,35,36,37);4,7-9,14-15,19,31H,2-3,5-6,10-13H2,1H3,(H,25,32)(H,26,27,28);1H4.
What are the key properties of 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane?
4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane has a molecular weight of 1004.26 g/mol, XLogP of 9.47, 19 rotatable bonds, 7 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(buta-1,3-dien-2-ylamino)-N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]benzamide;N-[3-[[8-ethyl-2-[2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]phenyl]prop-2-enamide;methane is sourced from PubChem (CID 158189049), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).